New Publications From the Smith Breast Center

Archive

April - June 2008

Arpino, G., Wiechmann, L., Osborne, C.K., Schiff, R. Cross-Talk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance. Endocr Rev. 2008 29(2):217-233. Epub ahead of print. [PDF]

Creighton, C.J., Osborne, C.K., van de Vijver, M., Foekens, J.A., Klijn, J., Horlings, H., Nuyten, D., Wang, Y., Zhang, Y., Chamness, C.G., Hilsenbeck, S.G.,  Lee, A.V., Schiff, R.  Molecular profiles of progesterone receptor (PR) loss human breast tumors. Submitted Lancet.

Li. X., Lewis M.T., Huang J., Gutierrez C., Osborne C.K., Wu M., Hilsenbeck S.G., Pavlick A., Chamness G., Wong H., Rosen J., and Chang J.C. (2008) “Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.” J. Natl. Cancer Inst. 2008 May 7;100(9):672-9. Epub 2008 Apr 29. [PDF]

January - March 2008

Massarweh, S., Osborne, C.K., Creighton, C., Qin, L., Tsimelzon, A., Huang, S., Weiss, H., Rimawi, M., Schiff, R.  Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classical estrogen receptor genomic function. Cancer Res 68(3):826-833, 2008. [PDF]